16
22
22
Biosimilar Red Tape Elimination Act
10/18/2025, 8:05 AM
Summary of Bill HR 5526
H.R. 5526, introduced in the 119th Congress on September 19, 2025, aims to enhance the standards for determining the interchangeability of a biological product with its reference product.
Read the Full Bill
Current Status of Bill HR 5526
Bill HR 5526 is currently in the status of Bill Introduced since September 19, 2025. Bill HR 5526 was introduced during Congress 119 and was introduced to the House on September 19, 2025. Bill HR 5526's most recent activity was Referred to the House Committee on Energy and Commerce. as of September 19, 2025
Bipartisan Support of Bill HR 5526
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
3Democrat Cosponsors
3Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 5526
Primary Policy Focus
Alternate Title(s) of Bill HR 5526
To improve the requirements for making a determination of interchangeability of a biological product and its reference product.
To improve the requirements for making a determination of interchangeability of a biological product and its reference product.
Comments
Sponsors and Cosponsors of HR 5526
Latest Bills
PROTECT Our Kids Act
Bill HR 1069December 5, 2025
Combating the Lies of Authoritarians in School Systems Act
Bill HR 1005December 5, 2025
Transparency in Reporting of Adversarial Contributions to Education Act
Bill HR 1049December 5, 2025
Made in America Manufacturing Finance Act
Bill HR 3174December 5, 2025
Small Business Regulatory Reduction Act of 2025
Bill HR 2965December 5, 2025
DUMP Red Tape Act
Bill HR 4305December 5, 2025
Improving Access to Workers’ Compensation for Injured Federal Workers Act of 2025
Bill HR 3170December 5, 2025
Make the District of Columbia Safe and Beautiful Act
Bill HR 5103December 5, 2025
SPEED Act
Bill HR 4776December 5, 2025
National Park System Long-Term Lease Investment Act
Bill HR 4931December 5, 2025